Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.54B 1.35B 1.26B 1.15B 2.17B 148B 2.2B 14.93B 5.83B 72.89B 5.78B 5.66B 252B P/E 2026 *
30.4x
P/E 2027 * 16.5x
Enterprise Value 2.88B 2.53B 2.35B 2.16B 4.05B 277B 4.12B 27.91B 10.91B 136B 10.8B 10.57B 471B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.57x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+6.63%
1 week+2.81%
Current month+10.19%
1 month+9.34%
3 months+87.23%
6 months+66.30%
Current year+59.34%
1 week 18.29
Extreme 18.29
19.84
1 month 17.01
Extreme 17.01
20.26
Current year 8.7
Extreme 8.7
20.26
1 year 8.7
Extreme 8.7
20.26
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Director/Board Member 64 12/12/2023
Chairman 64 03/01/2012
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
3/7/26 Tax

Chief Financial Officer

-5,226 0.0067%
1/7/26 Free

Executive/Senior Manager

11,180 0.0144%
1/7/26 Free

Executive/Senior Manager

5,590 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+6.63%+2.81%+50.95%-56.95% 1.54B
+2.29%+2.36%-18.56%-8.74% 180B
+1.46%+0.01%-10.47%-6.46% 107B
+1.58%+0.65%+6.73%+61.49% 60.29B
-1.13%-2.60%+27.02%+55.00% 50.19B
+2.22%-1.14%-15.63%-44.81% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-44.95% 27.61B
-7.67%-8.39%+24.55%-12.97% 23.1B
+1.63%-1.73%-7.11%-8.13% 20.86B
Average +1.15%-1.73%+4.21%-7.39% 54.55B
Weighted average by Cap. +1.30%-0.39%-6.63%+0.94%

Financials

2026 *2027 *
Net sales 1.68B 1.47B 1.37B 1.26B 2.36B 161B 2.4B 16.26B 6.35B 79.35B 6.29B 6.16B 274B 1.73B 1.52B 1.41B 1.3B 2.44B 167B 2.47B 16.78B 6.56B 81.91B 6.49B 6.35B 283B
Net income 42.73M 37.53M 34.9M 32.03M 60.18M 4.12B 61.11M 414M 162M 2.02B 160M 157M 7B 74.56M 65.49M 60.9M 55.89M 105M 7.18B 107M 723M 283M 3.53B 280M 274M 12.21B
Net Debt 1.34B 1.18B 1.09B 1B 1.88B 129B 1.91B 12.98B 5.07B 63.36B 5.02B 4.92B 219B 1.18B 1.03B 961M 881M 1.66B 113B 1.68B 11.41B 4.46B 55.67B 4.41B 4.32B 192B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
24/07/26 USD 19.79 +6.63% 901,081
23/07/26 USD 18.56 -1.38% 609,266
22/07/26 USD 18.82 -1.00% 802,847
21/07/26 USD 19.01 +0.64% 785,902
20/07/26 USD 18.89 -1.87% 715,131
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
19.79USD
Average target price
18.62USD
Spread / Average Target
-5.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock